PRKACB Antikörper (C-Term)
Kurzübersicht für PRKACB Antikörper (C-Term) (ABIN7296674)
Target
Alle PRKACB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Recognizes endogenous levels of PKA C beta protein.
-
Produktmerkmale
- Rabbit polyclonal antibody to PKA C beta
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human PKA C beta.
-
-
-
-
Applikationshinweise
- WB (1:500 - 1:1000), IH (1:100 - 1:200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))
-
Andere Bezeichnung
- PKA C beta
-
Hintergrund
- CAMP-dependent protein kinase catalytic subunit beta, PKA C-beta
-
Gen-ID
- 5567, 18749, 293508
-
UniProt
- P22694, P68181, P68182
-
Pathways
- AMPK Signaling, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-